首页> 外文期刊>Canadian Association of Radiologists journal >Canadian association of radiologists consensus guidelines for the prevention of contrast-induced nephropathy: Update 2012
【24h】

Canadian association of radiologists consensus guidelines for the prevention of contrast-induced nephropathy: Update 2012

机译:加拿大放射科医生协会预防造影剂肾病的共识指南:2012年更新

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Purpose Contrast-induced acute kidney injury or contrast-induced nephropathy (CIN) is a significant complication of intravascular contrast medium (CM). These guidelines are intended as a practical approach to risk stratification and prevention. The major risk factor that predicts CIN is pre-existing chronic kidney disease. Methods Members of the committee represent radiologists and nephrologists across Canada. The previous guidelines were reviewed, and an in-depth up-to-date literature review was carried out. Results A serum creatinine level (SCr) should be obtained, and an estimated glomerular filtration rate (eGFR) should be calculated within 6 months in the outpatient who is stable and within 1 week for inpatients and patients who are not stable. Patients with an eGFR of ≥ 60 mL/min have an extremely low risk of CIN. The risk of CIN after intra-arterial CM administration appears be at least twice that after intravenous administration. Fluid volume loading remains the single most important measure, and hydration regimens that use sodium bicarbonate or normal saline solution should be considered for all patients with GFR < 60 mL/min who receive intra-arterial contrast and when GFR < 45 mL/min in patients who receive intravenous contrast. Patients are most at risk for CIN when eGFR < 30 mL/min. Additional preventative measures include the following: avoid dehydration, avoid CM when appropriate, minimize CM volume and frequency, avoid high osmolar CM, and discontinue nephrotoxic medications 48 hours before administration of CM.
机译:目的造影剂引起的急性肾损伤或造影剂引起的肾病(CIN)是血管内造影剂(CM)的重要并发症。这些准则旨在作为一种风险分层和预防的实用方法。预测CIN的主要危险因素是已存在的慢性肾脏疾病。方法该委员会的成员代表加拿大的放射科医生和肾脏科医生。审查了以前的指南,并进行了深入的最新文献审查。结果应获得稳定的门诊患者血清肌酐水平(SCr),并在6个月内计算估计肾小球滤过率(eGFR),对于住院患者和不稳定患者则应在1周内计算其估计值。 eGFR≥60 mL / min的患者发生CIN的风险极低。动脉内CM给药后发生CIN的风险至少是静脉内给药后的两倍。体液负荷仍然是唯一最重要的措施,对于所有接受动脉内造影的GFR <60 mL / min的患者以及当GFR <45 mL / min的患者,应考虑使用碳酸氢钠或生理盐水的水合方案接受静脉造影的人当eGFR <30 mL / min时,患者发生CIN的风险最高。其他预防措施包括:避免脱水,在适当的情况下避免CM,最小化CM的量和频率,避免高渗性CM,并在服用CM前48小时停用肾毒性药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号